Bicarbonate

Bicarbonate

SCHEMBL363671

CC(C)(C)N(C(=O)c1ncc(-c2nc(N3CCOCC3)c3ncn(CC(F)(F)F)c3n2)cn1)C(C)(C)C.O=C(O)O.O=C(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 14/20 0.48
PIK3CA P42336 13/20 0.48
MTOR P42345 8/20 0.48
PIK3R1 P27986 8/20 0.48
PIK3CD O00329 4/20 0.48
PIK3CB P42338 3/20 0.48
PIK3CG P48736 3/20 0.48
HDAC3 O15379 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NCOR2 Q9Y618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL366010 0.88 PIK3CA (0.48) HDAC1PIK3CAMTORPIK3R1PIK3CD
Bicarbonate SCHEMBL364149 0.88 PIK3CA (0.50) HDAC1PIK3CAMTORPIK3R1PIK3CD
Bicarbonate SCHEMBL13674675 0.87 HDAC1 (0.53) HDAC1PIK3CAMTORPIK3R1PIK3CD
Bicarbonate SCHEMBL363717 0.85 PIK3CA (0.46) HDAC1PIK3CAMTORPIK3R1PIK3CD
Bicarbonate SCHEMBL363581 0.85 PIK3CA (0.46) HDAC1PIK3CAMTORPIK3R1PIK3CD
SCHEMBL799551 0.82 MTOR (0.51) HDAC1PIK3CAMTORPIK3R1PIK3CD
SCHEMBL13674676 0.80 PIK3CA (0.60) HDAC1PIK3CAMTORPIK3R1PIK3CD
SCHEMBL336979 0.80 PIK3CA (0.67) HDAC1PIK3CAMTORPIK3R1PIK3CD
Bicarbonate SCHEMBL366205 0.79 PIK3CA (0.44) HDAC1PIK3CAMTORPIK3R1PIK3CD
Bicarbonate SCHEMBL366554 0.77 PIK3CA (0.46) HDAC1PIK3CAMTORPIK3R1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071476-A1 MORPHOLINOPURINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-03-22 US disclosed
US-8097622-B2 Morpholinopurine derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-01-17 US disclosed
EP-2336132-A1 MORPHOLINOPURINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2011-06-22 EP disclosed
US-20100130492-A1 MORPHOLINOPURINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130492-A1 MORPHOLINOPURINE DERIVATIVES MTOR, RICTOR, PIK3R1 HDAC1 385/4885PIK3CA 22/4885MTOR 1/4885
US-20120071476-A1 MORPHOLINOPURINE DERIVATIVES MTOR, RICTOR, PIK3R1 HDAC1 385/4885PIK3CA 22/4885MTOR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.